ArticleCancer immunology, immunotherapy : CII2009

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.

Craig Gedye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.